Dosing regimens for 2-hydroxy-6-((2-(1-isopropyl-1h-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde | Patent Number 11020382

US 11020382 B2
Application Number15368142
Publication NumberUS 20170157101 A1
Pendency4 years, 6 months, 2 days
Filled DateDec 2, 2016
Priority DateDec 4, 2015
Publication DateJun 8, 2017
Expiration DateDec 3, 2035
Inventor/ApplicantsEleanor L. Ramos
Athiwat Hutchaleelaha
Joshua Eli Lehrer-Graiwer
ExaminesCORNET, JEAN P
Art Unit1628
Technology Center1600
Assignments
Global Blood Therapeutics Inc.
Current
Global Blood Therapeutics Inc.Pfizer
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.